<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Special AT-rich sequence-binding protein 1 (SATB1) is a global gene regulator that has been reported to confer malignant behavior and associate with poor prognosis in several <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> forms </plain></SENT>
<SENT sid="1" pm="."><plain>SATB1 expression has been demonstrated to correlate with unfavourable <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> characteristics in <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e>, but its association with clinical outcome in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) remains unclear </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we examined the prognostic impact of SATB1 expression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, and its association with important molecular characteristics; i.e. beta-catenin overexpression, microsatellite instability (MSI) screening status, and SATB2 expression </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Immunohistochemical expression of SATB1 and beta-catenin was assessed in tissue microarrays with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> from 529 incident <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cases in the prospective population-based Malmö Diet and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Study, previously analysed for SATB2 expression and MSI screening status </plain></SENT>
<SENT sid="4" pm="."><plain>Spearmans Rho and Chi-Square tests were used to explore correlations between SATB1 expression, clinicopathological and investigative parameters </plain></SENT>
<SENT sid="5" pm="."><plain>Kaplan Meier analysis and Cox proportional hazards modelling were used to explore the impact of SATB1 expression on <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> specific survival (CSS) and overall survival (OS) </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: SATB1 was expressed in 222 (42%) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cases and negative, or sparsely expressed, in adjacent colorectal mucosa (n = 16) </plain></SENT>
<SENT sid="7" pm="."><plain>SATB1 expression was significantly associated with microsatellite stable <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> (p &lt; 0.001), beta-catenin overexpression (p &lt; 0.001) and SATB2 expression (p &lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>While not prognostic in the full cohort, SATB1 expression was significantly associated with poor prognosis in SATB2 negative <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> (HR = 2.63; 95% CI 1.46-4.71; p(interaction) = 0.011 for CSS and HR = 2.31; 95% CI 1.32-4.04; p(interaction) = 0.015 for OS), remaining significant in multivariable analysis </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: The results of this study demonstrate that SATB1 expression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> is significantly associated with beta-catenin overexpression, microsatellite stability and SATB2 expression </plain></SENT>
<SENT sid="10" pm="."><plain>Furthermore, SATB1 expression is a factor of poor prognosis in SATB2 negative <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Altogether, these data indicate an important role for SATB1 in colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> and suggest prognostically antagonistic effects of SATB1 and SATB2 </plain></SENT>
<SENT sid="12" pm="."><plain>The mechanistic basis for these observations warrants further study </plain></SENT>
<SENT sid="13" pm="."><plain>VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1922643082772076 </plain></SENT>
</text></document>